APA-viite

Buchanan, V., Sullivan, W., Graham, C., Miles, L., Jugl, S. M., Gunda, P., . . . Kirkham, B. (2018). Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK. Pharmacoeconomics.

Chicago-tyylinen lähdeviittaus

Buchanan, Vanessa, Will Sullivan, Chris Graham, LaStella Miles, Steffen Marc Jugl, Praveen Gunda, Anna Halliday, ja Bruce Kirkham. "Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK." Pharmacoeconomics 2018.

MLA-viite

Buchanan, Vanessa, et al. "Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK." Pharmacoeconomics 2018.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.